Search research articles
Contact Us
Filters
Showing results (71-80 of 107) with videos related to
Page
of 11
Sort By:
Oncogene
|
June 22, 2021
PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs
Chia-Hung Chen, Bo-Wei Wang, Yu-Chun Hsiao, et al.
Cancer Research
|
January 19, 2012
Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1
Chia-Wei Li, Weiya Xia, Longfei Huo, et al.
American Journal of Cancer Research
|
March 21, 2020
Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer
Yu-Yi Chu, Clinton Yam, Mei-Kuang Chen, et al.
Gut
|
March 24, 2019
Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade
Ying Zhu, Jing Yang, Da Xu, et al.
Nature Communications
|
May 17, 2018
STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
Jung-Mao Hsu, Weiya Xia, Yi-Hsin Hsu, et al.
Cancer Cell
|
July 23, 2019
Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy
Heng-Huan Lee, Ying-Nai Wang, Weiya Xia, et al.
Cancer Research
|
January 14, 2016
EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape
Seung-Oe Lim, Chia-Wei Li, Weiya Xia, et al.
Journal of Medicinal Chemistry
|
February 13, 2010
Antitumor agents. 272. Structure-activity relationships and in vivo selective anti-breast cancer activity of novel neo-tanshinlactone analogues
Yizhou Dong, Qian Shi, Huei-Chen Pai, et al.
Cancer Research
|
March 12, 2020
Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity
Linlin Sun, Chia-Wei Li, Ezra M Chung, et al.
Haematologica
|
January 21, 2018
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
Ziduo Li, Xinsheng Ju, Kenneth Lee, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 107) with videos related to
Sort By:
Page
of 11
Oncogene
|
June 22, 2021
PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs
Chia-Hung Chen, Bo-Wei Wang, Yu-Chun Hsiao, et al.
Cancer Research
|
January 19, 2012
Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1
Chia-Wei Li, Weiya Xia, Longfei Huo, et al.
American Journal of Cancer Research
|
March 21, 2020
Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer
Yu-Yi Chu, Clinton Yam, Mei-Kuang Chen, et al.
Gut
|
March 24, 2019
Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade
Ying Zhu, Jing Yang, Da Xu, et al.
Nature Communications
|
May 17, 2018
STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
Jung-Mao Hsu, Weiya Xia, Yi-Hsin Hsu, et al.
Cancer Cell
|
July 23, 2019
Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy
Heng-Huan Lee, Ying-Nai Wang, Weiya Xia, et al.
Cancer Research
|
January 14, 2016
EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape
Seung-Oe Lim, Chia-Wei Li, Weiya Xia, et al.
Journal of Medicinal Chemistry
|
February 13, 2010
Antitumor agents. 272. Structure-activity relationships and in vivo selective anti-breast cancer activity of novel neo-tanshinlactone analogues
Yizhou Dong, Qian Shi, Huei-Chen Pai, et al.
Cancer Research
|
March 12, 2020
Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity
Linlin Sun, Chia-Wei Li, Ezra M Chung, et al.
Haematologica
|
January 21, 2018
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
Ziduo Li, Xinsheng Ju, Kenneth Lee, et al.
Page
of 11